Population of Interest

All patients with Chemical, Biological, Radiological and/or Nuclear (CBRN) exposure/injury

Intent

1. Perform CRESS assessment
2. Perform MARCHE² assessment and interventions
3. Reassess patient to monitor for changes related to chemical toxidromes, biological syndrome, acute radiation syndrome and/or nuclear exposure

Performance / Adherence Metrics

1. CRESS assessment is documented
2. Appropriate Antidote was administered
3. Changes related to chemical toxidrome, biological syndromes, acute radiation syndrome, and/or nuclear exposure are documented.

Data Source

• Patient Record
• Department of Defense Trauma Registry (DoDTR)

System Reporting & Frequency

The above constitutes the minimum criteria for PI monitoring of this CPG. System reporting will be performed annually; additional PI monitoring and system reporting may be performed as needed.

The system review and data analysis will be performed by the Joint Trauma System (JTS) Chief and the JTS PI team.

Responsibilities

It is the trauma team leader’s responsibility to ensure familiarity, appropriate compliance, and PI monitoring at the local level with this CPG.